SCHEMBL7913175

SCHEMBL7913175

CC1=C(C)N2C=C(Cc3ccc(N)cc3)C=C(c3cccc(Cl)c3)C2N1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
IKBKE Q14164 1/20 0.31
STK4 Q13043 1/20 0.31
STK3 Q13188 1/20 0.31
LRRK2 Q5S007 1/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
ALOX12 P18054 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
PGR P06401 1/20 0.30
CCNB2 O95067 1/20 0.30
CCNE2 O96020 1/20 0.30
CDK1 P06493 1/20 0.30
CDK4 P11802 1/20 0.30
CCNB1 P14635 1/20 0.30
CCND1 P24385 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7920535 0.88 DHFR (0.33) TAAR1IKBKESTK4STK3LRRK2
SCHEMBL7917010 0.84 MAOB (0.33) MAOBTAAR1IKBKESTK4STK3
SCHEMBL7902850 0.83 PGR (0.33) ALDH1A1LMNAMAPTALOX12SMN1; SMN2
SCHEMBL7915330 0.76 MEN1 (0.36)
SCHEMBL7911301 0.75 NLRP3 (0.35) ALDH1A1LMNASMN1; SMN2PGR
SCHEMBL7915334 0.71 DHFR (0.32) TAAR1IKBKESTK4STK3LRRK2
SCHEMBL7902988 0.67 GRIN1 (0.32) LMNASMN1; SMN2
SCHEMBL7916993 0.65 ESR2 (0.35) ALDH1A1LMNAMAPTALOX12PGR
SCHEMBL7902852 0.65 NPC1 (0.34) STK4STK3LRRK2MAPTSMN1; SMN2
SCHEMBL7902845 0.64 PIM1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010059838-A2 PDE4 INHIBITORS SELECTIVE FOR THE LONG FORM OF PDE4 FOR TREATING INFLAMMATION AND AVOIDING SIDE EFFECTS DECODE GENETICS EHF (IS) 2010-05-27 WO disclosed